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ABSTRACT 
Background: By 2050, 27 million people will need some type of long-term care service, most of 
whom will have multiple chronic diseases. Longer life spans and aging baby boomers will 
double the population of Americans aged 65 years or older during the next 25 years to about 72 
million. Since two out of every three older Americans have multiple chronic conditions, long-
term care and end-of-life (EOL) care is going to continue growing as a significant healthcare 
burden.  Palliative care, particularly home-based palliative care, can help to reduce healthcare 
costs at the end of life. 
 
Purpose/Approach: This review seeks to examine literature surrounding home-based palliative 
care in terms of 1) clinical effectiveness, 2) cost, 3) cost-effectiveness, 4) quality of life and 
patient satisfaction, and 5) recommendations for healthcare policy and practices. Research 
articles were found through a comprehensive search of PubMed and GlobalHealth (EBSCO) 
databases. A policy brief will be included which will describe the aging population and the 
burden on the U.S. healthcare system, opportunities for home-based palliative care, and policy 
recommendations. 
 
Review of Literature: Evidence shows that home-based palliative care compared to palliative 
care in other environments may result in fewer hospitalizations, fewer hospital days, fewer ED 
visits, and fewer physician office visits. Home-based palliative care reduces the likelihood of 
readmission to a hospital within 30 days and increases the likelihood of completing an advanced 
directive. It has shown to be cost-effective and result in lowered spending at a healthcare system 
and an individual level. Home-based care patients and their families report high levels of quality 
of life and satisfaction with their care. 
 
Recommendations: A primary obstacle is the financial burden for patients since many insurers, 
public and private, do not cover home-based palliative care. A barrier related to getting timely 
access to palliative care is physicians and other healthcare staff not initiating conversations 
around palliative care or EOL issues. Recommendations that will help remove barriers to care 
include revising the Medicare hospice benefit to have less restrictive eligibility for home-based 
care, providing incentives to healthcare providers for discussing and integrating palliative care, 
and systematically training and educating health professionals on palliative care issues. 
 
Conclusion: As the U.S. population continues to get older and suffer from multiple chronic 
conditions, millions of people are going to require long-term care. Healthcare spending is also 
going to continue to increase among the elderly and sick. Ensuring affordable and timely home-
based palliative care to this population is a critical step in reducing healthcare costs and 
improving quality of life.  
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CHAPTER 1: INTRODUCTION 
It is estimated that by 2050, 27 million people will need some type of long-term care 
service, most of whom will have multiple chronic diseases (Giovanni, 2012). Longer life spans 
and aging baby boomers will double the population of Americans aged 65 years or older during 
the next 25 years to about 72 million (CDC, 2013). Since two out of every three older Americans 
have multiple chronic conditions, long-term care and end-of-life (EOL) care is going to continue 
growing as a significant healthcare burden (CDC, 2013). Treating patients with advanced illness 
at the end of life is costly and complex. Palliative care, particularly home-based palliative care, 
can help to reduce healthcare costs at the end of life. Currently, Medicare beneficiaries must 
choose between receiving treatment and receiving palliative care. Therefore many people who 
could benefit from quality palliative care are not receiving it due to choosing treatment. 
Palliative care is an essential service that should be accessible and affordable to anyone who 
needs pain management and supportive care while living with chronic conditions or other 
debilitating diseases.  
By the year 2030, adults over 65 will account for about 20 percent of the population. 
Americans are living longer into their 70s, 80s, and beyond. The percentage of Americans who 
are ages 85 to 94 grew by 30 percent between 2000 and 2010 (Werner, 2011). The aging 
population has wide-range implications for many facets of society, including the burden to the 
healthcare system as more people are living with chronic diseases. During the past century, a 
major shift has occurred in the leading causes of death for all age groups, including older adults, 
from infectious diseases and acute illnesses to chronic diseases and degenerative illnesses (CDC, 
2013). Heart disease has been the leading cause of death since 1920 and cancer has been the 
second leading cause of death since 1938 (CDC, 2013). These chronic conditions and others such 
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as stroke, chronic lower respiratory disease, Alzheimer’s and diabetes pose the greatest risks to 
older adults. 
According to a 2012 CDC report, there were 133 million Americans who had at least one 
chronic disease, and nearly 25 percent of those with a chronic disease had limitations in their 
activities of daily living. People with chronic diseases often have other health problems like 
substance abuse or addiction disorders, mental illness, dementia, or developmental disabilities. 
Those with multiple chronic conditions face an increased risk of unnecessary tests, adverse drug 
effects and avoidable hospitalizations (CDC, 2013). Long-term care is needed for many older 
adults who suffer from multiple chronic conditions. Treating chronic illnesses accounts for 66 
percent of the country’s healthcare budget and these expenditures are expected to continue to 
rise. Medicare spending alone is expected to rise from $555 billion in 2011 to $903 billion in 
2020 (CDC, 2013). Chronic conditions account for 95 percent of healthcare costs for older 
Americans (CDC, 2013). Furthermore, the cost of providing healthcare for someone older than 
65 is three to five times higher than the cost for someone younger than 65.  
With the aging, sicker population, there is an increasing importance to consider EOL care 
as an integral part of the healthcare system. Palliative care as a supportive service has expanded 
and transformed in the U.S. and will continue to grow. Healthcare systems and payers must 
increasingly respond to the increased demand of older adults with multiple chronic conditions 
who need care both in a healthcare setting as well as in their home. Due to the growing demand 
of supportive care for people who need pain management and enhanced quality of life, there 
should be an option to receive affordable home-based palliative care. However, there are too 
often barriers to receiving this care. 
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There is evidence that home-based palliative care can reduce the cost of care, as well as 
provide higher quality of care. This article reviews the literature on home-based palliative care 
based on its results in terms of clinical effectiveness, cost, cost-effectiveness and quality of life, 
and recommends policies and practices to ensure affordable and timely care. 
 
DEFINING PALLIATIVE CARE AND THE GROWING NEED 
The World Health Organization (WHO) provides a definition of palliative care: 
Palliative care is an approach that improves the quality of life of patients and their 
families facing the problems associated with life-threatening illness, through the 
prevention and relief of suffering by means of early identification and impeccable 
assessment and treatment of pain and other problems, physical, psychosocial and 
spiritual. 
 Longer life expectancies, changing illness trajectories and advances in medical 
technology have changed the historical view of palliative care (Meghani, 2004). Palliative care is 
distinct from hospice care or EOL care in that it is not solely for those who are dying, but for 
those whom alleviation of suffering and improvement of quality of life are relevant goals 
(Meghani, 2004). Instead of a focus solely on treating the illness or condition, palliative care 
responds to the whole patient and family, accepting individual preferences, values and goals 
(National Consensus Project, 2009). In other words, EOL care can be considered palliative care, 
but palliative care is not necessarily EOL care.  
Palliative care provides an “extra layer of support that can be provided alongside disease-
oriented treatments” (Hughes & Smith, 2014). Patients who need palliative care include those 
with chronic conditions, serious acute illnesses, longer-than-anticipated length of stay, or those 
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experiencing major complications (Verret & Rohloff, 2013). An effective palliative care program 
fosters clear communication among clinicians, patients, and families, as well as establishes and 
focuses on clear patient care goals (Verret & Rohloff, 2013). As this paper will showcase, 
effective palliative care programs have demonstrable measures of public benefit, including cost 
savings, increased patient satisfaction and reduced hospital length of stay. 
Palliative care expands traditional disease-model medical treatments to include the goals 
of enhancing quality of life, optimizing function, helping with decision making, and providing 
opportunities for personal growth (Snapp, 2010). It affirms life by supporting patient and family 
goals, including hope for cure or life-prolongation, as well as hope for peace and dignity through 
the course of illness, the dying process and death. Comprehensive and patient-centered care 
manages pain and other symptoms, as well as incorporates psychosocial and spiritual care 
(Snapp, 2010). 
 The need for palliative care is going to grow substantially in the next decades. From 2000 
to 2010, more than 1,000 new hospital-based palliative care programs have been created (Hughes 
& Smith, 2014). In 2000, 25 percent of large U.S. hospitals had a palliative care team, compared 
with 66 percent in 2010. However, palliative care continues to be too often unknown, 
underutilized or misunderstood (Verret & Rohloff, 2013). 
 There is a major opportunity for palliative services in the U.S. to be offered in the 
patient’s home.  Most people prefer to receive care in one’s home as opposed to a nursing home 
or hospital due to the familiar surroundings of home and community (Panasci, 2009). In this 
environment, the patient would have less opportunity for exposure to infectious agents and the 
sole attention of the caregiver.  
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BARRIERS TO PALLIATIVE CARE ACCESS 
There are problems with insurance coverage for some who seek home-based palliative 
care. For instance, Medicare is an acute-level insurer and will only cover home care if the 
patient’s condition requires short-term or intermittent care (Panasci, 2009). Palliative care, on the 
other hand, may continue for an unknown amount of time until the patient improves or passes 
away. 
 Anecdotal evidence has described the struggle of some who have wanted to have care at 
home instead of the hospital, but barriers would not allow it. One New York Times article (2014) 
describes the story of Joseph Andrey who had been discharged to a nursing home over and over 
again, but would not be allowed to go home because neither Medicaid nor Medicare would cover 
home care. For-profit hospice companies only agreed to provide home visits if the doctor 
certified that Mr. Andrey only had six months to live.  
In the New York Times article (2014), Dr. Joan Teno, a gerontologist and author of 
“Dying in America” says: “We have these frail older people moving about in the medical-
industrial complex that we’ve constructed. It’s all about profit margins. It’s not about caring for 
people.” Teno (2013) found that most Medicare beneficiaries over the age of 65 received 
treatment in a hospital in their last days and this percentage has increased since 2000. Transfers 
of older patients among facilities and home have steadily increased since 2000. Also, only about 
one third of Medicare beneficiaries die at home (Teno, 2013). 
According to the Centers for Medicare and Medicaid’s (CMS) (2013) definition of 
Medicare benefit, hospice is restricted to patients with a terminal illness with a prognosis of six 
months or less to live who agree to forego “curative” care. Bonebrake et. al. (2010) describes 
barriers around physicians initiating palliative care discussions and patients who may seek 
Home-based palliative care  Behm 
10 
 
palliative care but fear doctors and loved ones will think they are “giving up” or seeking to 
forego treatment. There is a need for people at high risk of death and disease, but are not eligible 
or not interested in hospice. For instance, Bonebrake et. al. (2010) describes a case study in 
which a man with prostate carcinoma was provided palliative care consultation for pain 
management and supportive care. He did not have a prognosis of six months or less to live but he 
did need his symptoms and pain managed. Home-based palliative care can be an important 
option in these situations. 
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PURPOSE 
This review seeks to examine literature surrounding home-based palliative care in terms 
of 1) clinical effectiveness, 2) cost, 3) cost-effectiveness, 4) quality of life and patient 
satisfaction, and 5) recommendations for healthcare policy and practices. The research will 
determine whether home-based palliative care is a viable option worth pursuing and making 
policy changes. This will influence whether patients should have equal opportunities for home-
based palliative care and other types of palliative care. A policy brief will be included which will 
describe the aging population and the burden on the U.S. healthcare system, opportunities for 
home-based palliative care, and policy recommendations. 
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APPROACH 
 This capstone reviews the literature on home-based palliative care in terms of clinical 
effectiveness, cost-effectiveness and quality of life of the patient and family. The body of 
research will inform policy and practice recommendations that will help ensure affordable and 
timely home-based palliative care to those who need it. Research articles were found through a 
comprehensive search of PubMed and GlobalHealth (EBSCO) databases. The databases included 
Medline, CINAHL, PAIS International, Web of Science, Cochrane Library, and Academic 
Search Complete. Articles found through the databases were peer-reviewed and written in the 
English language.  The EBSCO disciplines searched were “Complementary and Alternative 
Medicine,” “Consumer health,” “Health & Medicine,” “Psychology,” “Public Health,” and 
“Social Sciences and Humanity.” 
Search terms included “home-based,” “palliative or hospice,” “effectiveness” or “cost” or 
“cost-effectiveness” or “quality of life” or “satisfaction.” Articles searched were published 
between January 2003 and January 2015. All articles that referred to home-based palliative care 
were reviewed. Articles that compared home-based palliative care to other types of palliative 
care were included but not a requirement for inclusion. Due to the limited number of U.S. based 
studies, articles from other developed countries similar to the U.S. were included. Commentaries 
on home-based palliative care were reviewed for background information. Gray literature 
produced by government agencies was also included. 
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CHAPTER 2: REVIEW OF LITERATURE 
CLINICAL EFFECTIVENESS 
In general, palliative care has been shown to produce many clinical benefits including 
quality of life improvement, better quality of care with less aggressive EOL care, and less 
emotional distress (Hughes & Smith, 2014). This section of the literature review will describe 
studies related to the effectiveness of palliative care in general, as well as outpatient palliative 
care. Additionally, it will describe the clinical effectiveness of home-based palliative care based 
on the following indicators: 1) hospital and emergency department (ED) visits, 2) place of death, 
3) completion of advance directives, 4) symptom management, and 5) readmission rates.  
There have been several studies demonstrating the possible prolongation of life with the 
use of palliative care or hospice. For example, Verret & Rohloff (2013) describe a Massachusetts 
study that followed patients with lung cancer who received palliative care along with standard 
treatment, and patients who had standard treatment only. They found that although the palliative 
care patients received less aggressive EOL care than the standard care patients, the palliative care 
patients lived an average of 2.7 months longer (Verret & Rohloff, 2013).  
 There has also been some evidence of effectiveness in outpatient palliative care. For 
instance, Scheffey et. al. (2013) showed patients in clinic-based outpatient palliative care had, on 
average, longer length of stays at hospice than patients who did not receive palliative care. This 
indicates that the patients were living longer while in hospice. There is less evidence of the 
effectiveness of home-based palliative care in comparison to inpatient palliative care, but the 
evidence is nonetheless important in showing that home-based care can actually offer improved 
benefit over standard care. 
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Hospital and ED visits 
Research shows that hospital visits, hospital utilization and ED visits are reduced when 
home-based palliative care is used. Lukas et. al. (2013) sought to evaluate a single, home-based, 
non-hospice, palliative medicine consultation practice that was fee-for-service. The particular 
practice called Optimizing Advanced Complex Illness Support (OACIS) serves patients with a 
variety of diseases regardless of their specific prognosis or utilization of curative treatments. 
Patients are seen in homes or assisted-living facilities, but not skilled nursing facilities. The 
purpose of each visit was to improve symptoms and coordinate care, while also reconciling 
patient and family expectations and plans with the actual illness severity (Lukas et. al., 2013). 
Researchers evaluated hospital and ED visits and costs with a pre-post, single-patient group 
design. The longitudinal analyses indicated that there were significant reductions in hospital 
utilization after the 18-month study period, including number of hospitalizations and total 
hospital days. There was no change in the probability of an ED visit. While causality cannot be 
claimed, the results are encouraging given the emerging interest in home-based palliative 
medicine. 
The primary limitation of Lukas et. al. (2013) was the absence of a randomized control 
design. The referral to a palliative medicine service may reflect selection bias and factors that 
determine referral were not measured. Authors also only had access to hospital utilization data 
from one healthcare network. Regardless, the article suggests that this delivery model can bring 
palliative services to patients much earlier in the illness trajectory than currently possible with 
hospice. 
The next study shows less hospital use and fewer ED visits for the palliative care group 
compared to a usual care group. Brumley et. al. (2003) was conducted at the Home Health 
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Department at Kaiser Permanente in southern California between March 1999 and August 2000 
to compare patients enrolled in a palliative care intervention to those receiving usual care. The 
Palliative Care Program at Kaiser Permanente is an interdisciplinary home-based system of 
healthcare designed to provide treatment to enhance comfort and improve the quality of a 
patient’s life. The patients could decide to continue restorative treatment while also receiving 
symptom control, patient education, and psychosocial services. The comparison group receiving 
“usual care” was treated for conditions and only received home care when they met the 
Medicare-certified criteria of an acute condition.  
 Data were collected from patient interviews and from the Kaiser Permanente service 
utilization database. During the two year study, 300 patients were included in the sample. 
Hospital and ED visits were significantly lower for the palliative care group than comparison 
group patients. Comparison group patients had twice as many ED visits and four times as many 
hospital days than the palliative care group. The palliative care group also had lower physician 
office visits and less skilled nursing use (Brumley et. al., 2003). 
 Brumley et. al. (2007) completed a randomized, control trial in order to compare standard 
care with an in-home palliative care program, specifically in the programs’ ability to improve 
patient outcomes. The trial was conducted at two managed care sites in Hawaii and Colorado. 
The patients were those who had 12 months or less to live and had visited the ED or hospital at 
least once within the previous year. When referred to the program, they were randomly assigned 
to standard care or in-home palliative care. The proportion of patients who died during the study 
period was not significantly different between the study groups (Brumley et. al., 2007).  
 There were, however, significant differences between the groups in terms of service use, 
with 20 percent of palliative care members going to the ED compared to 33 percent of usual care 
Home-based palliative care  Behm 
16 
 
members. Furthermore, 36 percent of those receiving palliative care were hospitalized, compared 
with 59 percent of those enrolled in usual care. After adjusting for survival, age, and severity of 
illness, authors found that enrollment in the palliative care program reduced hospital days by 
4.36 and ED visits by 0.35 (Brumley et. al., 2007).  
Other developed countries have also analyzed the effects of home-based palliative care. 
A population-based study from Spain compared ED admissions and inpatient days among cancer 
patients in a geographic area with a palliative home care team and in an area without a palliative 
home care team (Alonso-Babarro et. al., 2013). Authors found that the palliative care patients 
used emergency services and inpatient services less frequently. The authors found that the use of 
hospital resources during the last two months of life was significantly lower in the palliative 
home care area (Alonso-Babarro et. al., 2013).  However, a limitation is that the variations may 
have been due to other regional differences not measured rather than whether the palliative home 
care was located in that area.  
 
Place of death 
The place of death is an important indication of whether a patient’s wishes are met or not. 
One narrative appraisal by Higginson et. al. (2013) looked at the science of dying at home. This 
debate is increasingly relevant for all palliative care stakeholders and constitutes a public health 
issue due to the rising numbers of deaths and increasing health expenditures.  Preferences for 
place of care and death show that home is the main preference, followed by hospice, but there is 
a need for a greater understanding of factors underlying change of preferences and how often or 
why these change over time. Kerr et. al. (2014) indicated that enrollment in home-based 
palliative care may increase the likelihood of dying at home rather than in another setting. 
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Brumley et. al. (2003) found that 90 percent of palliative care patients died in their home 
compared to 57 percent of the comparison group patients. These findings remain significant even 
after controlling for days of service and severity of illness. Limitations of Brumley et. al. (2003) 
was the lack of a randomized controlled trial and the limited generalizability. 
 Brumley et. al. (2007) found that 71 percent of palliative care patients died at home, 
compared with 51 percent of those receiving usual care. One limitation of the study was the 
inadequate sample of individual minority groups, as well as limited generalizability since it was 
conducted within a managed care setting (Brumley et. al., 2007). This study provides strong 
clinical evidence supporting the provision of palliative care in the home of terminally ill patients. 
 Alonso-Babarro et. al. (2013) found in their Spain-based study that the frequency of 
deaths in the hospital was significantly lower among patients in the geographic area with 
palliative home care compared to the area without palliative care. The probability of a hospital 
death increased in direct relationship with the number of visits to the emergency center or 
inpatient hospital and with the number of inpatient days. The article is another piece of evidence 
that improvements can be made in EOL care through public health policy and home deaths 
should be an important part of the conversation. 
There have been two systematic reviews on the effectiveness of home palliative care 
services. A 2011 systematic review by Shepperd et. al. looked at four randomized controlled 
trials to compare EOL care at home with inpatient or hospice care. Two trials were conducted in 
the United States, one in Norway and one in the United Kingdom. In terms of place of death, 
authors found that those receiving EOL home care were significantly more likely to die at home 
compared with those receiving usual care, including hospice care, inpatient care and routinely 
available primary healthcare (Shepperd et. al., 2011). A more recent 2013 systematic review by 
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Gomes et. al. looked at studies of patients largely with advanced cancer but also congestive heart 
failure and other chronic illnesses. Meta-analysis showed that home palliative care increased 
odds of dying at home. 
A better understanding of the factors influencing preferences for place of care and death, 
including age, culture, social conditions or previous care experiences, could inform the model of 
factors affecting place of death and contribute to the development of responsive palliative care 
services and clinical practice (Higginson et. al., 2013).  
 
Advance directives 
Advance directives are important for ensuring that a patient’s EOL wishes are adhered to 
in a time when the patient may not be able to communication for him or herself. Kerr et. al. 
(2014) looked at the clinical impact of a home-based program through a hospice-private payer 
partnership. Home Connections (HC) is a home-based palliative care program established in 
Cheektowaga, New York in 2008.  The HC team includes a palliative care-trained registered 
nurse coordinator, social worker, trained volunteers, and a palliative care physician. Two local 
private insurance payers support the program through a per member/per month fee. Referrals 
come from physicians, palliative care agencies, local insurers, or the community. For this study, 
administrative and clinical data were gathered retrospectively (Kerr et. al., 2014). Approximately 
88 percent of HC patients had one or more completed advance directives, with 71 percent of 
those without advance directives before enrollment subsequently completing them. This 
indicates that home-based palliative care programs can increase the rate of actionable advance 
directive completion.  
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Symptom management 
Another indicator of care effectiveness is the successful management of pain and other 
symptoms. Kerr et. al. (2014) examined symptoms of patients in the palliative care group and the 
usual care group. The average score for all symptoms (i.e. anxiety, appetite, depression, dyspnea, 
nausea, pain, weakness, and well-being) improved during the first 10 weeks of enrollment in HC. 
All of the symptom improvements were statistically significant, except those for depression and 
pain. After the 10th week of enrollment, scores of all symptoms remained stable on average (Kerr 
et. al., 2014). Results of this study showed that enrollment in home-based palliative care 
appeared to result in multiple symptom improvement. A primary limitation of the study was the 
retrospective design and absence of a comparison group (Kerr et. al., 2014). 
 In a 2011 systematic review by Shepperd et. al. did not find a difference between home-
based and inpatient or hospice care in terms of patients’ functional status and psychological well-
being or cognitive status. However, there was a difference in caregivers’ report of pain control 
between the two groups and assessment of depression and anxiety. Caregivers in the home-based 
care group reported less pain and less depression and anxiety (Shepperd et. al., 2011). A 2013 
systematic review by Gomes et. al. found small but significant beneficial effects of home 
palliative care services compared to usual care on reducing symptom burden for patients.  
 
Readmission rates 
An important component of clinical effectiveness is readmission rates. If home-based 
palliative care services can reduce the 30-day readmission rate, they may have an important role 
to play in post-acute care, particularly in Accountable Care Organizations (ACOs). Hughes & 
Smith (2014) found that palliative care programs in general helped to reduce readmissions by 50 
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percent. There is evidence that suggests home-based palliative care can reduce hospital 
readmission rates as well. For instance, Lukas et. al. (2013) found that the probability of a 30-day 
readmission was reduced after an 18-month study period of a home-based palliative care 
practice.  
One study was conducted in the University of Pennsylvania Health System post-acute 
care program (Penn Homecare and Hospice Services) among patients who were admitted to a 
home care program or a palliative home care program (Ranganathan et. al., 2013). The palliative 
home program was staffed by hospice nurses rather than home care nurses, and had access to a 
phone line that provides 24-hour access to a hospice nurse. An interdisciplinary team discusses 
the palliative care patients biweekly, which is different than the standard home care group. 
Researchers calculated the average treatment effect on treated patients, which is a measure of the 
impact of palliative care on 30-day readmission, compared to what their readmission rates would 
have been in the regular home care group (Ranganathan et. al., 2013). Results showed that 
palliative care patients had a 30-day readmission probability of 9.1 percent compared to 17.2 
percent in the home care group. Therefore, palliative home care programs may have the potential 
to improve patient-centered outcomes by reducing readmission rates. More research may be 
needed on how palliative care may reduce the 30-day readmission rate (Ranganathan et. al., 
2013).  
    
COSTS 
 Not only do home-based palliative care programs need to be effective, but they should 
not be more costly than other alternatives. Changes in Medicare reimbursement (i.e. 30-day 
readmission policies) as well as the mandate through the 2010 Affordable Care Act that requires 
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all people to have health insurance make it imperative for health systems to develop models that 
reduce healthcare costs. One way to reduce healthcare costs is by delivering care in non-hospital 
settings. Lukas et. al. (2013) found that reducing unnecessary hospital visits and treatments may 
benefit hospital finances, even in a fee-for-service environment. This section provides evidence 
that home-based palliative care programs are less costly than care in other settings in terms of 
inpatient/ hospital costs, patient costs, and societal costs. 
 
Inpatient/ hospital costs  
There have been several articles that reviewed the costs of home-based palliative care. 
Hughes & Smith (2014) found that palliative care programs helped to lower overall healthcare 
costs by reducing the cost of inpatient stays and allowing each hospital to calculate the financial 
savings from adding or expanding their palliative care team. The savings estimate is partly based 
on reductions in inpatient length of stay, but it also includes savings from moving a patient from 
a high-cost venue such as the intensive care unit (ICU) to a lower-cost setting such as usual or 
palliative care—so called “cost avoidance.” 
 Morrison et. al. (2008) compared direct costs of patients who were cared for by a 
palliative care team with direct costs of matched patients who were not covered by palliative 
care. The study analyzed data from eight hospitals and found that the use of palliative care saved 
an average of more than $7.5 million a year. This does not include indirect cost savings nor 
savings from unwanted or unnecessary procedures which would make the cost savings even 
greater. Savings included significant reductions in pharmacy, laboratory and intensive care costs 
(Morrison et. al., 2008). The authors concluded that an average 400-bed hospital seeing 5,000 
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patients a year could achieve annual net savings of $1.3 million by implementing a palliative 
care program. 
 
Patient costs 
Brumley et. al. (2003) found that patients enrolled in the palliative care group had an 
average $6,580 reduction in cost from the average cost for those in the comparison group 
receiving usual medical care. Average cost of care for the comparison group was $14,570 and for 
those in palliative care, the average cost was $7,990. Therefore, receiving palliative care reduced 
medical costs of care by 45 percent. 
 Brumley et. al. (2007) completed a randomized, control trial to compare standard care 
with an in-home palliative care program, specifically in the programs’ ability to reduce the costs 
of medical care at the end of life. Authors found significant differences in the cost of care 
between home-palliative care and standard care. The analysis revealed that overall costs of care 
for those enrolled in the palliative care program were 33 percent less than those receiving 
standard care. The average cost per day incurred by palliative care recipients ($95.30) was 
significantly lower than that of usual care group members ($212.80). Authors concluded that 
providing a palliative care team to homebound patients can have a positive effect in reducing 
costs of care at the end of life. 
 
Societal costs 
A study out of Canada sought to examine the societal costs of home-based palliative care 
and the socio-demographic and clinical factors that account for variations in costs over the 
course of the palliative trajectory (Guerriere et. al., 2010). Patients were recruited from Mount 
Sinai Hospital in Toronto and costs were assessed between time of admission and death. 
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Caregivers were interviewed every two weeks. The Ambulatory and Home Care Record (AHCR) 
was used to comprehensively measure costs of services from a societal perspective by 
quantifying publicly financed care and private family costs. The majority of the sample reported 
receiving both publicly funded medications and out-of-pocket medication costs. The average 
monthly cost of care per patient was $24,549. Costs were higher closer to death compared with 
time points more distant from death (Guerriere, et. al., 2010). One limitation of the report is that 
the study relied on self-reports obtained through phone interviews. Also, the results may not 
necessarily be generalized to people receiving services from other types of palliative care 
programs. Lastly, approximate prices had to be used to derive the costs (Guerriere, et. al., 2010). 
Another Canadian study analyzed the resource utilization and costs of a home-based 
palliative care service over 15 months (Klinger et. al., 2013). The Niagara West End-of-Life 
Care Project was designed to provide enhanced interdisciplinary home-based shared-care in a 
rural community setting. The project collaborated with primary care teams and a palliative care 
consultant or team. Most of the patients enrolled in the project had a cancer diagnosis, while a 
few had advanced heart disease, chronic obstructive pulmonary disease, amyotrophic lateral 
sclerosis, and Alzheimer’s. Frequently used services included specialized nursing, homemaking, 
equipment rentals, and occupational and physical therapy. Most patients and families accessed 
bereavement services, psycho-spiritual care and pain management.  
The average length of stay in the program was 145 days. The total costs for all patient-
related services during the study were about $1,625,658 or $17,112 per patient (Klinger et. al., 
2013). A majority of the billing was for specialized nursing services, homemaking and 
equipment charges. These costs were well within the parameters of the U.S. Medicare Hospice 
Benefits and on par with the per diem funding assigned for long-term care homes. This is 
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important because it indicates that home-based palliative care is not more expensive than hospice 
or other long-term care facilities, and gives credence to the argument that Medicare benefits 
should include home-based palliative care. 
Limitations of this article include the relatively small number of study participants and 
short timeframe that hamper generalizability. It was also a retrospective review using datasets 
from one community hospital. Authors conclude that this analysis indicates that home-based 
service provision is less costly than hospital-based alternatives (Klinger et. al., 2013). Future 
projects should use economic analysis from the societal perspective in the study design from the 
beginning to allow for comparisons across settings. 
 
COST-EFFECTIVENESS 
The literature in this section first examines the cost-effectiveness of palliative care in 
general and reviews the cost-effectiveness of home-based palliative care. Most settings for 
palliative care are shown to be cost-effective. Guerriere et. al. (2010) describes how 
opportunities to improve the cost-effective allocation of palliative care services may be 
calculated by comparing the incremental gains in satisfaction to the incremental cost of care over 
the palliative trajectory, between care providers, and across alternative levels of service intensity. 
 
Community-based palliative care 
Higginson et. al. (2009) showed through a cost-effectiveness analysis based on the 
Palliative Care Outcome scale and the Zarit Carer Burden Inventory, a caregiver self-report 
measure, that the intervention group with palliative care had lower costs and better outcomes 
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47.3 percent of the time, and higher costs and better outcomes 48 percent of the time. Therefore, 
it was cost-effective about half of the time but always clinically effective. 
Although not a home-based care program, one report describes the cost-effectiveness of a 
palliative care program in a rural Alabama community hospital (McGrath et. al., 2013). The 
average cost per day for the palliative care recipients was $754 and $1,027 for non-palliative care 
recipients. Palliative care patients had a net savings of $273 per day. The palliative care cost 
savings were calculated to be $148,471, which yielded a net cost savings of $46,971 (McGrath 
et. al., 2013). 
 
Home-based palliative care 
The most rigorous cost-effectiveness analysis of home-based palliative care was a 
prospective cost-effective analysis of the Palliative Care Extended Packages at Home (PEACH) 
pilot randomized control trail in Sydney, Australia (McCaffrey et. al., 2013). Community care in 
New South Wales is provided by a specialist palliative care team, general practitioners, and 
community nurses. Patients enrolled in the PEACH trial had complex or unstable symptom 
management and high care needs. Participants were randomized to receive PEACH or usual care. 
Specialist palliative care services and PEACH costs were estimated using hourly rates of local 
salaries, agency staff costs and equipment hire. Incremental net monetary benefit and cost-
effectiveness acceptability curves were estimated at potential threshold values for one extra day 
at home. 
 PEACH participants had 13.1 average days at home, which was one more day than usual 
care (McCaffrey et. al., 2013). PEACH costs varied widely with one high cost outlier attributable 
to a large number of additional nursing hours. Of participants who died, 56 percent were in the 
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PEACH pilot, and 80 percent were in usual care. The average direct cost associated with PEACH 
was $3,489 per participants and was offset by $2,450 inpatient cost savings. 
 Authors found that the incremental net monetary benefit over 28 days for PEACH versus 
usual care became positive when the threshold value for one extra day at home exceeded $1,068. 
When the high cost outlier was removed, it reduced the threshold value to $846. The cost-
effectiveness acceptability curve indicates the probability of PEACH being cost-effective versus 
usual care for potential threshold values for one extra day at home. Findings suggest home-based 
palliative care can reduce hospitalizations and associated costs (McCaffrey et. al., 2013). More 
research may be needed to determine if one extra day at home is meaningful to decision makers. 
 Limitations of the study include differences in baseline characteristics that may have been 
associated with home deaths between intervention groups. Also, informal care costs were not 
included and generalizability will be limited to care provided by similar costing and funding 
models. Authors found that most of the costs of intensive, home-based care packages are offset 
by reduced inpatient stays, while days at home are increased (McCaffrey et. al., 2013). These 
findings provide great support for the financial feasibility of home-based palliative care 
programs. 
 
QUALITY OF LIFE & PATIENT SATISFACTION 
The literature demonstrates that palliative care has implications for both patients and 
families. It is important to see improved quality of life, relief of suffering, and the enhancement 
of human dignity as a result of home-based palliative care. Families should also have improved 
coping, less distress, and more support through the care process. The patient-family care 
experience is of upmost importance for all palliative care services. 
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Hospitals are in the business of healing, and there is a point where curative care is no 
longer realistic (Verret & Rohloff, 2013). Healing is not just the curing of disease, but also 
holistically addressing the physical, psychosocial, emotional, and spiritual wellness of a patient. 
Palliative care provides a service to address the holistic care of patients and their families, 
especially when chronic or severe conditions are not curable or resolvable (Verret & Rohloff, 
2013). While palliative care can be administered in addition to curative treatment, many times it 
is in lieu of curative treatment. This section will review literature showing that home-based 
palliative care provides increased quality of life for patients and caregivers by looking at the 
following indicators: 1) patient satisfaction, 2) patient symptoms, and 3) caregiver satisfaction. 
 
Patient satisfaction 
Studies of home-based palliative care consistently indicate higher quality of life and 
patient satisfaction.  Brumley et. al. (2003) compared the satisfaction of patients in the palliative 
care group and comparison group when they enrolled and 60 days following enrollment. 
Satisfaction with services was significantly higher in the palliative care group 60 days following 
enrollment than at baseline (t= -2.57, p=0.01) while satisfaction remained the same for 
comparison group members (t= -0.5, p=0.6) (Brumley et. al., 2003). Kerr et. al. (2014) found that 
the patients, caregivers and physicians were consistently satisfied with the program throughout 
the study. 
 Brumley et. al. (2007) conducted a randomized control trial among patients in two health 
maintenance organizations in Hawaii and Colorado and there was no significant difference in the 
portion of participants reporting to be very satisfied at baseline or at 60 days after enrollment. 
Rates of satisfaction did increase in the intervention group at 30 days and 90 days after 
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enrollment, with 93 percent of those enrolled in the palliative care group very satisfied with care 
at 90 days after enrollment, compared with 81 percent of usual care patients. This indicates that 
an in-home palliative care program plus usual care can increase patient satisfaction compared 
with usual care alone (Brumley et. al., 2007). 
Similarly, a Japanese day hospice was evaluated to determine advanced cancer patients’ 
quality of life and satisfaction with day hospice (Miyashita et. al., 2008). A cross-sectional 
questionnaire was administered to patients cared for at day hospices or home palliative care 
services. Compared to national standard values, the average physical component summary and 
mental component summary was significantly lower in both the day hospice and home palliative 
care service patients and caregivers. For eight of the 11 questions, 70 percent or more patients 
were satisfied. Eighty percent of caregivers were satisfied about patient-related items and 
caregiver-related items (Miyashita et. al., 2008). Although advanced cancer patients and 
caregivers have a lower quality of life compared to the general population, patients and 
caregivers were mostly satisfied with the home palliative care based on this article. 
 
Patient symptoms 
Peters and Sellick (2006) describe the quality of life of cancer patients receiving inpatient 
and home-based palliative care. Authors compared the symptom experience, physical and 
psychological health status, level of personal control over the illness, and quality of life of 
patients in both groups. Symptoms were assessed using the Memorial Symptom Assessment 
Scale (MSAS), a self-report instrument. Physical health was assessed using the Palliative 
Performance Scale (PPS) and the Hospital Anxiety and Depression Scale (HADS) was used to 
indicate anxiety and depression. 
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The most prevalent symptoms (more than 70 percent) reported by the inpatient group 
were weakness, fatigue, dry mouth, sleeping during the day, and pain. The least prevalent 
symptoms (less than 20) were mouth sores and weight gain. For home-based patients, fatigue, 
pain, weakness and ﬂatulence were the most prevalent and diarrhea, headache, mouth sores and 
weight loss were the least prevalent symptoms (Table 1). Higher average scores were recorded 
for the inpatient group on all four symptom measures (Peters & Sellick, 2006). 
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Table 1- Peters & Sellik, 2006 
Symptom prevalence for inpatient and home-based groups (ranked for inpatient patients) 
  Inpatient   Home-based 
  n % n % 
Symptom         
Weakness 28 87.5 18 69.2 
Fatigue 27 84.4 21 80.8 
Dry mouth 24 75 17 65.4 
Sleeping during the day 24 75 15 57.7 
Pain 23 71.9 20 76.9 
Lack of appetite* 21 65.6 10 38.5 
Flatulence 19 59.4 18 69.2 
Thirst 18 56.3 11 42.3 
Belching* 17 53.1 7 26.9 
Nausea 16 50 12 46.2 
Diarrhoea** 15 46.9 3 11.5 
Constipation 15 46.9 12 46.2 
Shortness of breath 14 43.8 14 53.9 
Taste alteration 13 40.6 10 38.5 
Vomiting 12 37.5 7 26.9 
Sweating 12 37.5 8 30.8 
Dizziness 11 34.4 6 23.1 
Weight loss 11 34.4 5 19.2 
Cough 9 28.1 11 42.3 
Swelling of arms/legs 9 28.1 11 42.3 
Bad taste 9 28.1 11 42.3 
Headache 8 25 4 15.4 
Itchy skin 7 21.9 9 34.6 
Weight gain 5 15.6 6 23.1 
Mouth sores 4 12.5 4 15.4 
       
*P < 0.05; **P < 0.01         
 
Results showed that home-based patients had statistically signiﬁcantly higher physical 
health scores for physical status and lower depression scores. Although not statistically 
signiﬁcant, the home group also scored higher on the PPS and lower on the anxiety scale. The 
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home-based group scored signiﬁcantly higher on all personal control measures (control over 
daily symptoms, control over the course of the illness, and control over medical care and 
treatment). Both groups scored higher on “personal control over symptoms and medical care” 
and “treatment” than on “the course of the disease” (Peters & Sellick, 2006). 
The impact of disease on quality of life was less for patients at home than those receiving 
inpatient care on all measures. Although the two groups were similar on a number of measures, 
patients receiving home-based palliative care tended to have better physical and psychological 
health and quality of life. Home-based patients also experienced fewer adverse effects from their 
symptoms and reported having more control over their illness and treatment (Peters & Sellick 
2006). However, caution is needed when interpreting these ﬁndings given that a higher 
proportion of patients in the home-based group were married, of Australian descent, had private 
health insurance and were less likely to be living alone. 
An Australian study compared the prevalence of anxiety and depression in palliative care 
patients being treated at home with those being treated as inpatients (Austin et. al., 2011). HADS 
was used to measure anxiety and depression symptoms in the patients. The Karnofsky 
Performance Status Scale (KPS) was used as an indicator of functional status. The home-treated 
patients and inpatients did not differ significantly in terms of average age or gender, but did 
differ in functional status and socioeconomic status.  
The groups did not differ significantly on HADS depression, anxiety or total scores 
(Austin et. al., 2011). Younger age and lower KPS scores were associated with higher HADS 
scores. About 20 percent of all the palliative care patients showed meaningful anxiety and 
depression which underscores the importance of addressing psychological distress in palliative 
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care services. Appropriate and equal staff resources should be used on palliative care inpatients 
and those being treated at home. 
 
Caregiver satisfaction 
Within a larger article about cost variations in home-based palliative care, Guerriere et. 
al. (2010) measured satisfaction of caregivers using the Quality of End-of-Life Care and 
Satisfaction with Treatment (QUEST) scale. The majority of caregivers reported being either 
very satisfied with the quality of care provided by physicians and nurses (71 percent and 60 
percent, respectively) or satisfied (26 percent and 33 percent, respectively). 
Guerriere et. al. (2013) used QUEST to interview family caregivers about their 
satisfaction with home-based physician and nursing palliative care services. Satisfaction is 
defined as the degree to which expectations of several aspects of care are met. The authors 
designed a prospective, longitudinal cohort study that measured satisfaction with care from 
admission until death. This particular palliative care program provides community 
multidisciplinary care, including symptom management and practical/emotional support to 
individuals at home 24 hours per day, 7 days per week. Study participants were interviewed 
every two weeks and reported their perceptions of satisfaction over the previous two days. 
 A majority of the caregivers were female and were generally either spouses or children of 
the patient (Guerriere et. al., 2013). Data from 748 interviews was analyzed and the majority of 
interviews resulted in high satisfaction with both nursing and physician care. On five different 
categories, caregivers reported being very satisfied with physician care (an average 87 percent) at 
a higher rate than they did for nursing care (an average 71.2 percent). The categories included 
bedside manner, common courtesy, way of talking to patient, clinical and technical skills in 
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treating patient, and concern for patient as an individual (Table 2). Quality-of-care parameters 
included questions about the provider spending enough time with the patient, arriving on time, 
accessibility, attentiveness and personal concern. Authors found that quality-of-care parameters 
are strong predictors of satisfaction (Guerriere et. al., 2013). 
Table 2- Guerriere et. al. 2013 
Caregivers' perceived satisfaction by scale items and professional category 
  Nurses (N= 274) Doctors (N= 154) 
  n % n % 
          
Bedside manner       
very satisfied 199 72.6 137 89.5 
dissatisfied 75 27.4 16 10.5 
Common courtesy       
very satisfied 196 71.5 138 90.2 
dissatisfied 78 28.5 15 9.8 
Way of talking to patient       
very satisfied 191 69.7 136 88.9 
dissatisfied 83 30.3 17 11.1 
Clinical and technical skills in treating 
patient       
very satisfied 189 69 134 87.6 
dissatisfied 85 31 19 12.4 
Concern for patient as an individual       
very satisfied 201 73.4 128 83.7 
dissatisfied 73 26.6 25 16.3 
Overall satisfaction       
very satisfied 185 67.5 116 75.8 
dissatisfied 89 32.5 37 24.2 
Months to death       
0 40 26 47 17.1 
1 38 24.7 59 21.5 
2 to 3 37 24 64 23.4 
4+ 39 25.3 104 38 
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Sociodemographic variables were not shown to be significant predictors of satisfaction. 
The article demonstrates that healthcare providers should be meeting quality parameters, in part 
to increase family caregivers’ satisfaction with home-based palliative care services. One 
limitation of the study was not measuring the patients’ perceptions, only the caregivers’ 
perceptions. The results may not be generalizable to individuals receiving services at other types 
of palliative care programs (Guerriere et. al., 2013). 
Another article based in Australia sought to assess how family caregivers were supported 
in three home-based palliative care services (Thomas et. al., 2010). Focus groups with health 
professionals were conducted to determine what services were currently available for the 
caregivers, how well the services met caregivers’ needs, and perceived barriers to supporting 
caregivers. A file audit was also conducted to determine the frequency of actual support services 
received by caregivers. Authors found that there were not formalized procedures for assessing 
and responding to family caregiver needs in a comprehensive way (Thomas et. al., 2010). 
 
SUMMARY 
 The existing literature suggests that home-based palliative care compared to palliative 
care in other environments may result in fewer hospitalizations, fewer hospital days, fewer ED 
visits, and fewer physician office visits. There is evidence that the probability of readmission to a 
hospital within 30 days is less for home-based patients. The research also shows that those 
receiving home-based care are more likely to die in their home, which is the preference for a 
majority of people. Other positive benefits include a higher likelihood of completed advanced 
directives by those receiving palliative care at home. Completing advanced directives improves 
the chance that patients will receive life-saving care, or not receive care if desired, in times when 
they are unable to speak for themselves. 
Home-based palliative care  Behm 
35 
 
An ideal healthcare situation for a person with a chronic disease or debilitating condition 
would be to have his or her treatment and palliative care options described by a team of 
healthcare professionals, including an option for home-based palliative care. This option would 
be presented once the healthcare team, patient and family agree that care can be adequately 
managed at the home and a plan for curative care, or lack thereof, is understood by all parties. 
Many articles suggest that home-based care may be the preferred option for patients who are in 
better health, wish to remain independent, believe that they have control over the effects of their 
illness and treatment, and who have supportive networks at home. Alternatively, inpatient care, 
particularly in hospice, is the more likely choice for patients who are very ill or require intensive 
symptom management, or where the family is unable to cope with the burden of care. If home-
based care is chosen, it may be delivered integrally by a specialized palliative care team or 
individual physicians and nurses, depending on the patient’s medical condition. Appointments in 
the hospital or other healthcare settings can still be arranged at designated intervals or as needed 
when testing or other follow-up services cannot be adequately performed in the home setting. 
 Several articles found that there was a cost reduction by bringing care to the home. Most 
of the costs were derived from specialized nursing, homemaking, and equipment. Furthermore, 
these home-based costs were found to be well within the parameters of the U.S. Medicare 
Hospice Benefits. Therefore Medicare should cover beneficiaries’ home-based care costs at the 
same level as hospice and inpatient settings. An incentive for covering home-based care through 
government insurance is cost reduction, which may help to reduce overall U.S. healthcare costs. 
Other cost-effectiveness articles found a net savings when people received care at home as 
opposed to an inpatient setting. Home-based palliative care is an effective and encouraging 
option for reducing healthcare spending.  
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 Quality of life and satisfaction was found to be favorable in home-based patients and 
often times higher than inpatient patients and families. Various studies showed patient 
satisfaction to be higher after 30 days of care, 60 days of care, and 90 days of care. Other 
evidence showed high percentages of home-based patients who are very satisfied or satisfied 
with physicians and nurses. Some results showed higher physical health and lower depression for 
home-based patients. Home-based groups were also found to score higher on personal control 
measures. Just as important as patient well-being is family and caregiver well-being. Research 
presented evidence that families of home-based palliative care patients had high satisfaction with 
physicians and nursing staff. The evidence indicates that wider availability and accessibility of 
home-based palliative care would be highly valued by patients and families who want to spend, 
in many cases, the end of the patient’s life together in the comfort of their own home. 
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CHAPTER 3: RECOMMENDATIONS 
 This article presents important findings that suggest home-based palliative care can be 
clinically effective, cost-effective and improve quality of life among patients and their families. 
However, there are many barriers that prevent affordable and timely access to care. A primary 
obstacle is the financial burden for patients since many insurers, public and private, do not cover 
home-based palliative care. For instance, Medicare, one of the nation’s largest health insurers, 
only provides the hospice benefit as an EOL option for patients. The current Medicare hospice 
benefit only covers palliative and support services for patients designated to have a terminal 
illness and a life expectancy of six months or less (CMS, 2013). The hospice benefit will not 
cover treatment costs, room and board, care in an emergency room or inpatient facility, nor care 
from any hospice provider not set up by the hospice medical team (CMS, 2013). By electing to 
receive the benefit, patients forfeit any conventional treatment for the condition. This may feel to 
the patient that they are “giving up” or resigning themselves to death. Due to the large number of 
older adults suffering from multiple chronic conditions who could benefit physically and 
psychosocially from supportive care, there should be insurance coverage for palliative care 
without the requirement to have a terminal illness. When care is not covered by insurance, the 
financial burden of paying for care out-of-pocket is so large that it is often unmanageable and 
unrealistic. 
A barrier related to getting timely access to palliative care is physicians and other 
healthcare staff not initiating conversations around palliative care or EOL issues. This may be 
due to the lack of incentives offered to healthcare professionals to initiate EOL conversations and 
a lack of education around palliative care and when to discuss the topic. Doctors may feel that 
they do not have enough time, resources, or knowledge to have these types of discussions with 
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their patients and therefore do not initiate the conversation until it is too late to have any valuable 
impact. 
These following recommendations serve to limit barriers to affordable and timely home-
based palliative care: 
1. Medicare benefit should include home-based palliative care without the 
requirement to forego treatment 
Medicare should cover home-based palliative care similarly to the way Medicare covers 
hospice benefits but without the requirement to be terminally ill, have six months or less to live, 
and to forego treatment. The benefit would cover doctor services, nursing care, medical 
equipment and supplies, prescription drugs, counseling and other care as described in the 2013 
Medicare Hospice Benefits. Palliative care should be available for those patients who wish to 
receive care at home, but may also want to continue getting life-saving treatment.  Patients 
should not feel forced to be in an inpatient setting to receive care that can be provided in the 
home. The current Medicare hospice model does not address patients with multiple chronic 
conditions and ambiguous prognoses. Research has shown that providing palliative care earlier 
in the course of disease leads to better health outcomes, higher satisfaction with care and 
reductions in healthcare costs (California HealthCare Foundation, 2013). It has also been shown 
that there is considerable value in the concurrent delivery of palliative and curative care. 
Calls have certainly been made to increase the availability of and access to palliative care 
services in the U.S. healthcare system (Meier, 2011). Medicare beneficiaries are receiving care 
that is fragmented and uncoordinated and does not take into account their overall care needs.  
Evidence supports the need for fundamental changes in the design of the U.S. healthcare system 
by adjusting our current hospice benefit to better meet the needs of patients or developing a new, 
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‘‘pre-hospice’’ palliative care benefit that provides a bridge between standard medical care and 
hospice care (Brumley et. al., 2007). For the past several years, policymakers have debated 
reform of the Medicare hospice benefit, in terms of eligibility, financing, and structure 
(MEDPAC, 2012). In 2009, Congress gave CMS the authority to revise the hospice payment 
system. Since the CMS Secretary had not exercised that authority, the recommendation was 
printed again in the 2014 Medicare Payment Advisory Commission (MEDPAC) report. 
The 2010 Affordable Care Act (ACA) is requiring that data be collected by CMS 
regarding hospice quality (MEDPAC, 2014). ACA mandates a three-year demonstration to test 
the effect on quality and cost of allowing simultaneous hospice and conventional care. Through 
the pilot Medicare Care Choices Model, CMS is providing an option for Medicare beneficiaries 
to receive palliative care services from certain hospice providers while concurrently receiving 
services provided by their curative care providers. CMS will evaluate whether providing hospice 
services will improve the quality of life, increase patient satisfaction, and reduce Medicare 
expenditures. The results of this study will be important for implications on how Medicare 
hospice benefits are structured in the future. 
Medicare is already spending about $15 billion on hospice a year and 34.5 percent of the 
hospice patients receive a week or less of care (NHPCO, 2015). If home-based palliative care 
was offered to those same patients earlier in their illness trajectory, costs could potentially be 
avoided by reducing unnecessary care and managing high-need, “at risk” patients. 
Medicare needs to replace the eligibility requirement for hospice benefits to include those 
who have Medicare Part A and are certified by a physician as having an advanced or late-stage, 
progressive or degenerative chronic illness in which the disease or physical ailment significantly 
worsens, grows, or spreads over time. While a prognosis of six months or less to live is difficult 
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to certify and should not be required, the illness should be considered “advanced”, cause a 
significant amount of impairment to the patient’s daily activities, and require continuous medical 
care, as determined by a primary healthcare provider. Examples of progressive disease would 
include Alzheimer’s disease, cancer, chronic obstructive pulmonary disorder, Huntington’s 
disease, multiple sclerosis, Parkinson’s disease and others as classified by the National Institutes 
of Health.  
 
2. Compensation to healthcare providers for discussing and integrating palliative care  
The 2014 Institute of Medicine report, “Dying in America,” was released by a committee 
of 21 experts that calls the U.S. EOL care system “broken” and recommends several ways to 
improve care. One of the recommendations is reimbursing providers to discuss EOL care and 
advance planning with their patients. Authors found that incentives under fee-for-service 
Medicare result in increased use of medical services and late enrollment in hospice, which can 
jeopardize the quality of EOL care and add to costs. Incentivizing provisions of comprehensive 
palliative care and discouraging the use of costly and unnecessary medical procedures can 
improve patient outcomes and reduce healthcare costs (IOM, 2014). The report recommends that 
the federal government require public reporting on quality measures, outcomes and costs 
regarding care near the end of life for programs like Medicare and encourage other healthcare 
delivery systems to do the same. There should be financial incentives for medical services that 
decrease the need for emergency room and acute care services, coordination of care across 
settings and providers, and improved shared decision making and advance care planning (IOM, 
2014). 
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The 2013 MEDPAC report also recommends a Medicare payment to compensate 
physicians or interdisciplinary teams for voluntary advanced care planning. This would help 
incentivize quality care and working with the patient and family to carry out their wishes. 
Advanced care planning may include discussions of where the patient would like to receive care 
and for how long he or she would want to be treated. According to the Dartmouth Atlas Brief 
(2013), Medicare spending in the last two years of life increased 15 percent between 2007 and 
2010 from $60,694 to $69,947 per patient. Furthermore, Riley (2010) found that about 25 
percent of the Medicare budget is spent on care during the last year of life. Nicholas et. al. (2011) 
found that advance directives specifying limitations in EOL care were associated with lower 
costs in regions were EOL spending was highest. The savings to Medicare due to reduced EOL 
spending would help offset the cost of Medicare-financed incentives to healthcare providers. 
Federal or state governments could subsidize incentives for private practice physicians 
contingent on meeting quality standards. 
Landers (2009) describes the Medical Home initiative using MEDPAC recommendations 
as a concept that creates a way for primary care clinicians to receive payment for added care 
coordination, care integration, quality improvement, and education activities for patients with 
chronic diseases. The extra payments would be accompanied by added requirements and 
accountability for outcomes. Providing compensation to physicians and other healthcare 
providers for discussing palliative care options and coordinating care would increase the number 
of patients who understand their care and treatment options. 
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3. Better training for health professionals on palliative care topics 
There needs to be improved training of health professionals on issues like patient-
centered care and palliative care as a longer term approach in improving care for patients with 
advanced illness. This training can be included in medical school curriculum, nursing school 
curriculum, and other healthcare training curriculum. According to the 2014 MEDPAC report, 
very short hospice stays are still common which indicates that patients enter hospice in the last 
week or so of their life, unable to receive the full benefit of palliative care. This may be due to 
physicians’ reluctance to have conversations about hospice or death, difficulty in some patients 
and families to accept death, and financial incentives in the fee-for-service system which value 
volume over quality (MEDPAC, 2014). Zhang et. al. (2009) found that patients who had an EOL 
conversation with their doctor had 36 percent lower expenses compared to those who did not 
have those discussions. 
The IOM report (2014) recommends improving palliative care training among all 
physicians. Educational institutions, credentialing bodies, accrediting boards, state regulatory 
agencies and healthcare delivery organizations should establish appropriate training, certification 
and licensure requirements to strengthen palliative care knowledge and skills of all physicians 
who care for patients with advanced illness (IOM, 2014). Basic palliative care competencies 
include communication skills, interprofessional collaboration and symptom management. 
Certifying bodies should require competency in palliative care, and educational institutions and 
professional societies should provide training throughout the professional’s career (IOM, 2014). 
Other entities like healthcare delivery organizations, academic medical centers, and teaching 
hospitals should increase the number of available training positions for specialty-level palliative 
care.  
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It is still engrained in the psyche of the American hospital system that healthcare 
professionals should continue treating the patient until the last possible moment. Additional 
training would help health professionals resist the idea that palliative care is the same thing as 
hospice and should be reserved for those who have a short time to live. Training of healthcare 
professionals needs to emphasize high-quality care and comfort of the patient, including home-
based palliative care options and advanced care planning. Acknowledging advanced illness and 
mortality provides an opportunity to deliver high standards of care, grounded in choice and 
responsiveness to needs for both the patient and their family.  
When palliative care is taught, results can be impressive. A systematic review by Bickel-
Swenson (2007) found that EOL educational curricula and clinical training found in a wide range 
of formats improved the competency of medical students. Authors found a 23 percent 
improvement in knowledge, a 56 percent improvement in feelings of competence, and a 29 
percent decrease in concerns. Improvements are already being made by several universities and 
associations. For example, George Washington University includes a standardized patient case 
on palliative care and a course on medical interviewing and decision making. The University of 
Rochester includes content on advance care planning, chronic pain management, and discussion 
of treatment goals. The Association of American Medical Colleges is in collaboration with the 
Coalition to Transform Advanced Care to identify relevant core competencies. 
 
CRITICISM 
There was debate in 2009 related to Medicare paying physicians to discuss EOL care 
with their patients, with critics calling them “death panels” out of fear that the physicians would 
ration healthcare to elderly patients. Some believe that government payment for counseling on 
EOL decisions would lead to more government regulation and oversight, and create a conflict of 
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interest between the government’s fiscal needs and patients’ medical needs. As a result of the 
controversy, the ACA did not include that piece of legislation. However, the 2014 IOM report 
emphasizes that the important question related to EOL discussions is whether patients near the 
end of their lives are getting the care they actually want. By reimbursing physicians to discuss 
EOL care, patients can be more informed and empowered to make decisions on how to spend 
their final days. Reimbursements should be tied to standards and quality measures so that the 
quality of patient care would be improved, not diminished. 
 There are also politically conservative critics who oppose any additional funding to 
Medicare, either to pay for additional benefits or for physician incentives. However, the research 
indicates that offering home-based palliative care not only can improve the quality of life of a 
vulnerable population, but can result in cost-savings at the individual and provider level. 
Healthcare costs are high and rising in the United States, and improving accessibility and 
affordability of home-based palliative care through Medicare is an opportunity to reduce EOL 
costs throughout the country. 
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CHAPTER 4: DISCUSSION 
The aging of the American population is quickly expanding the healthcare burden, in 
large part by the 66 percent of older adults who have multiple chronic conditions. Treating 
advanced illness and chronic conditions in the older population is complex and expensive. 
Medicare spending is expected to increase from $555 billion in 2011 to $903 billion in 2020. As 
the U.S. healthcare system struggles to keep up with the demand for care, there will be an 
increasing need for high-quality palliative care in all settings, but particularly home-based 
settings. Home-based palliative care has been shown to be at least equally effective as inpatient 
palliative care, less costly than inpatient care, and results in improved quality of life and patient 
satisfaction. Therefore, patients and their families should have the choice to use home-based 
palliative care when it is available, without the burden of financial or accessibility barriers.  
Providing this home-based option will greatly alleviate the strain on inpatient settings and 
will reduce hospital and patient costs. An approach toward high-quality care and coordination 
and away from over-treating or inappropriately treating patients will improve quality of life as 
well as reduce unnecessary medical costs. This is an opportunity that the U.S. healthcare system 
and Medicare cannot afford to ignore. It is critical that federal, state, and local regulatory and 
payment policies evolve to support the delivery of high-quality palliative care to a growing 
elderly population who often live for many years with the burden of serious, chronic illnesses 
(Unroe & Meier, 2013). Legislation needs to be passed to implement these policy changes. 
 
SUCCESSFUL PROGRAMS & MODELS 
There are opportunities for health systems to model home-based palliative care programs 
after successful HMO programs like Kaiser Permanente and other ACOs. The Kaiser 
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Permanente in-home program, offered as a standard benefit to most members, includes an 
interdisciplinary team of providers who manage patient’s symptoms and pain, provide emotional 
and spiritual support, and offer ongoing education about changes in the patient’s condition 
(AHRQ, 2009). The patients do not have to forgo curative care in this program. Brumley et. al. 
describes the evidence of a randomized controlled trial (2003) and a comparison-group study 
(2007) which shows that Kaiser Permanente’s program increased patient satisfaction, increased 
the portion of patients dying at home rather than in the hospital, and reduced ED visits, inpatient 
admissions, and costs. 
  The Pioneer ACO Model is designed for healthcare organizations and providers that are 
already experienced in coordinating care for patients across settings and allows them to move 
from a shared savings payment model to a population-based payment model, similar to the 
Medicare Shared Services Program (CMS, 2015). The model is designed to work in coordination 
with private payers by aligning provider incentives, which will improve quality and health 
outcomes among patients and achieve cost savings for Medicare, employers and patients (CMS, 
2015). There are currently 19 ACOs participating in this model and being evaluated for 
performance. This is an innovative example of changing payment models and providing 
incentives for high-quality, coordinated care.  
There are other ACO programs that can be adopted such as the Medicare Shared Savings 
Program which helps Medicare fee-for-service providers become an ACO, and the Advance 
Payment ACO model, which is a supplementary incentive program for selected participants in 
the Shared Savings Program. As home-based palliative care is implemented in various healthcare 
systems, there will be even more robust evidence to justify new practices offering this type of 
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care. Furthermore, as more healthcare organizations use home-based palliative care, it would be 
expected that insurance and payers will begin to cover these important services. 
 
ADVANCING POLICY RECOMMENDATIONS 
While policy recommendations are important, it is critical to understand the actions that 
must be taken to ensure the guidance provided is utilized and implemented through policy 
changes. An important first step is the engagement of all relevant stakeholders and participants 
impacted by the recommended changes to the hospice payment system. Kingdon (1995) provides 
a useful policy framework to inform efforts aimed at achieving policy change, suggesting a focus 
on “three streams” of policymaking – problems, policies (i.e., solutions), and politics. Kingdon 
suggests that if advocates can 1) help policymakers recognize their issue as an important 
problem, 2) develop attractive and feasible policy solutions, and 3) catalyze broad support 
among stakeholders that catalyzes political will, a policy window will open that allows for the 
adoption of the desired policy.  
 
Framing the problem 
 Efforts to frame the problem of lack of access to palliative care may benefit from 
guidance from Stone (1989) who suggests that causal arguments can lead to agenda-setting in 
politics. Stories framed in this manner can lead to emotional responses and increased support for 
proposed policy solutions. Casual arguments place blame or responsibility of a problem on a 
person or system and seeks to fix the problem through political means (Stone, 1989). An 
example of a narrative that is emotional and defines the problem is from a response submitted 
through the online public testimony questionnaire for the 2014 IOM report:  
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“We got hospice when my mother-in-law died, but only for 2 weeks. She declined 
steadily for 2 years before her death, as we bounced back and forth between hospital, 
nursing home, and home (with private-paid caregivers). It was a bad way to go, with 
much pain, suffering, and expense for her and our family. There were too many barriers 
to getting the care she needed. Medicare pays for all types of care that is unbeneficial 
(911 trips to the hospital, certain tests, treatments, medications, surgeries, and skilled 
nursing home stays for rehab, etc.). But it will not pay for the care people actually need 
during chronic, progressive illness—custodial care, comfort care, nursing care. We need 
to fix this.” 
This testimony is an example of a real problem that families of people at the end of their life face 
every day. When palliative care for those with advanced chronic illness is not affordable because 
insurance does not cover it and/or is not accessible because physicians do not discuss the 
patient’s options, there is a major financial and emotional strain on families and caregivers. 
Certifying six months or less to live is difficult for physicians since every illness progresses in 
different ways and over various lengths of time. Furthermore, Riley (2010) found that 25 percent 
of the Medicare budget is spent on care during the last year of life, which indicates large amounts 
of money is being spent on life-saving treatments which may or may not be desired by the 
patient or family. Often times in hospitals, the default is to treat and perform intensive 
procedures in attempts to prevent the death of a patient. With advanced care planning and 
integration of a palliative care team, patients can decide how much treatment they want and at 
what point they prefer to opt out of treatment. Promoting policy solutions to address this problem 
is essential to reducing EOL spending and improving quality of care for the aging population. 
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Promoting the policy solution 
As mentioned above, Medicare beneficiaries who have Medicare Part A should be 
eligible for hospice benefits if they are certified by a physician as having an advanced or late-
stage, progressive or degenerative chronic illness. Medicare should also compensate physicians 
or interdisciplinary teams for conducting advanced care planning with patients. In order to 
advance the policy recommendation for CMS to revise the hospice benefit and payment system, 
the MEDPAC commissioners must first vote on the MEDPAC recommendations. The 
Commission chairman, Glenn Hackbarth, and the vice chairman, Michael Chernew, may have 
influence over the opinions of the Commission’s 17 members.  
Once MEDPAC publishes a recommendation, a representative should introduce a bill to 
Congress that addresses modifications to the Medicare hospice benefits. The bill should be 
introduced during a lame duck period between November and the inauguration of officials early 
the next year, and with little fanfare in order to achieve bipartisan support. According to Mitchell 
& Washington (2014), members of Congress are three to four percent less likely to vote along 
party lines during lame duck sessions and more likely to vote for general interest. The MEDPAC 
recommendations will serve as strong evidence for support of the bill. Building political support 
among stakeholders and advocates is monumental for pushing the policy solution forward. 
 
Building political will 
Key health advocates can play an important role in promoting the bill and building 
political support. Organizations such as the Robert Wood Johnson Foundation, American 
Medical Association, AARP, the Center to Advance Palliative Care (CAPC) and the National 
Hospice and Palliative Care Organization (NHPCO) should provide leadership in making the 
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case to update the hospice payment system to Rep. Kevin Brady, the chairman of the House 
Committee on Ways and Means Subcommittee on Health. Part of the rationale for proposed 
changes was recently stated by Alice Rivlin, an economist and former U.S. Federal Reserve 
official in her May 2013 testimony before the House Committee on Ways and Means 
Subcommittee on Health. Ms. Rivlin stated: 
“Why reform Medicare? The main reason for reforming Medicare is not that the program 
is the principal driver of future federal spending increases, although it is. The main reason 
is not that Medicare beneficiaries could be receiving much better coordinated and more 
effective care, although they could. The most important reason is that Medicare is big 
enough to move the whole American health delivery system away from fee-for-service 
reimbursement, which rewards volume of services, toward new delivery structures, which 
reward quality and value. Medicare can lead a revolution in health care delivery that will 
give all Americans better health care at sustainable cost (Rivlin, 2013)” 
Rivlin’s testimony adds support to the effort to modify the Medicare hospice benefit to provide 
better care options to those with chronic disease. Other federal partners that may support the bill 
include the Administration of Aging, the Agency for Health Resources and Quality, and the 
Senate Commission on Long-Term Care, which issued detailed recommendations on the ways to 
strengthen supports for family caregivers. Advocates of passing legislation should lobby 
representatives in the House Committee on Ways and Means Subcommittee on Health months 
prior to the introduction of the bill so that once a policy window opens, swift action can be taken 
to introduce and pass the bill. 
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PROMOTING TRAINING & CREDENTIALING 
 Advocating for enhanced training and credentialing of physicians on palliative care, EOL 
care, and advanced care planning involves many stakeholders. The Accreditation Council on 
Graduate Medical Education needs to require palliative care education and clinical experience in 
programs for all specialties responsible for managing advanced serious illness (including primary 
care clinicians). For this to happen, there needs to be support from the following member 
organizations: the American Board of Medical Specialist, American Hospital Association, 
American Medical Association, Association of American Medical Colleges, and the Council of 
Medical Specialty Societies. The Liaison Committee on Medical Education requires accredited 
U.S. medical schools to teach EOL care but the requirement is vague and does not specifically 
mention palliative care and is not rigorously enforced through specific standards (IOM, 2014). 
Directors of the major medical associations need to urge the committee to clarify and specify this 
accreditation requirement. 
 Other stakeholders include the American Board of Hospice and Palliative Medicine 
which certifies physicians seeking to demonstrate competence in the palliative care field. 
Questions on EOL and palliative care need to be included on the U.S. Medical Licensing 
Examination which is a professional exam sponsored by the Federation of State Medical Boards 
(FSMB) and the National Board of Medical Examiners (NBME). Top leaders from CAPC and 
the NHPCO need to meet with the heads of FSMB and NBME to emphasize the importance of 
testing students on these healthcare issues. 
 Furthermore, Schools of Public Health should include EOL care in public health courses 
which can help lead future health care administrators and policy makers to incorporate principles 
of palliative care into health care systems. It is important to promote cross-collaboration and 
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coordination among the various educational institutions, credentialing bodies and accrediting 
boards to ensure a cohesive and integrated approach to improving palliative care knowledge 
among health professionals. 
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CONCLUSION 
As the U.S. population continues to get older and suffer from multiple chronic conditions, 
millions of people are going to require long-term care. Palliative care provides important 
physical, psychosocial, and spiritual services, as well as pain management, to provide comfort 
and quality of life to those at the end of their life or continuing curative treatment. Most people, 
when given an option, would choose to receive palliative or EOL care in the familial 
surroundings of their own home. In the next decades, palliative care is going to grow 
substantially in the United States. Healthcare spending is also going to continue to increase 
among the elderly and sick. Ensuring affordable and timely home-based palliative care to this 
population is a critical step in reducing healthcare costs and improving quality of life.  
Research shows that home-based palliative care is clinically effective, cost-effective and 
increases patient and family satisfaction. Recommendations that will help remove barriers to care 
include revising the Medicare hospice benefit to have less restrictive eligibility for home-based 
care, providing incentives to healthcare providers for discussing and integrating palliative care, 
and systematically training and educating health professionals on palliative care issues. There are 
successful programs and models that public and private healthcare systems can model their own 
programs after, document the results, and build the evidence base for home-based palliative care.  
The adoption of recommended policies will require a well-planned advocacy strategy that 
engages key stakeholders and target key constituencies and policymakers. As noted above, this 
strategy should include an established policy framework that is focused on communicating the 
problem effectively, promoting thoughtful and impactful policy solutions, and implementing 
approaches to build political will. It is imperative that improvements in quality of palliative care 
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and access to care are made so that all Americans, regardless of their financial status or medical 
prognosis, receive the highest quality care possible. 
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LIMITATIONS 
 While this article describes important information related to the clinical effectiveness, 
cost-effectiveness and quality of life through home-based palliative care, there are a few 
limitations that are important to address. Many of the articles lacked the strength of a randomized 
control design and also lacked generalizability due to the specific settings where each study took 
place. Additional research should be done with a strong study design to further compare home-
based palliative care and non-home based palliative care in the United States. More research 
should also be done to compare different models of home-palliative care and determine which 
ones work most effectively and efficiently. 
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APPENDIX: Policy Brief 
 
Addressing End-of-Life Care in America:  
The Opportunity for Home-Based Palliative Care 
 
The problem of America’s aging population and end-of-life care 
 
By 2050, 27 million people will need some type of long-term care service, most of whom 
will have multiple chronic diseases (Giovanni, 2012). Longer life spans and aging baby boomers 
will double the population of Americans aged 65 years or older during the next 25 years to about 
72 million (CDC, 2013). Since two out of every three older Americans have multiple chronic 
conditions, long-term care and end-of-life (EOL) care is going to continue growing as a 
significant healthcare burden (CDC, 2013).  
 
Treating patients with advanced illness at the end of life is costly and complex. Palliative 
care, particularly home-based palliative care, can help to reduce healthcare costs at the end of 
life. Palliative care is not solely for those who are dying, but for anyone whose goals are to 
alleviate suffering and improve their quality of life, including those at the end of their life. 
Currently, Medicare beneficiaries must choose between receiving treatment and receiving 
palliative care. Therefore many people who could benefit from quality palliative care are not 
receiving it due to choosing treatment. The need for palliative care is going to grow substantially 
in the next decades and there is a major opportunity for palliative services in the United States to 
be offered in the patient’s home.  Palliative care is an essential service that should be accessible 
and affordable to anyone who needs pain management and supportive care while living with 
chronic conditions or other debilitating diseases.  
 
Benefits of home-based palliative care 
 
Evidence shows that home-based palliative care compared to palliative care in other 
environments may result in fewer hospitalizations, fewer hospital days, fewer ED visits, and 
fewer physician office visits (Lukas et. al. 2013, Brumley et. al. 2003 & 2007, Alonso-Babarro 
et. al. 2013). Home-based palliative care also reduces the likelihood of readmission to a hospital 
within 30 days (Ranganathan et. al. 2013) and increases the likelihood of completing an 
advanced directive (Kerr et. al. 2014). Completing advanced directives improves the chance that 
patients will receive life-saving care, or not receive care if desired, in times when they are unable 
to speak for themselves. 
 
Home-based palliative care has shown to be cost-effective and result in lowered spending 
at a healthcare system and an individual level (Lukas et. al 2013, Hughes & Smith 2014, 
Morrison et. al. 2008, Brumley et. al. 2003 & 2007, Guerriere et. al. 2010, Klinger et. al. 2013). 
Patients in home-based palliative care are more likely to die in their own home, which is the 
preference for a majority of people (Brumley et. al. 2003 & 2007, Alonso-Babarro et. al. 2013, 
Shepperd et. al. 2011, Gomes et. al., 2013). Furthermore, home-based care patients and their 
families report high levels of quality of life and satisfaction with their care (Brumley et. al. 2003 
& 2007, Miyashita et. al. 2008, Guerriere et. al. 2013, Thomas et. al. 2010). 
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Barriers to home-based palliative care 
 
 Many barriers prevent affordable and timely access to palliative care. A primary obstacle 
is the financial burden for patients since many insurers, public and private, do not cover home-
based palliative care. For instance, Medicare, one of the nation’s largest health insurers, only 
provides the hospice benefit as an EOL option for patients. The current Medicare hospice benefit 
only covers palliative and support services for patients designated to have a terminal illness and a 
life expectancy of six months or less (CMS, 2013). By electing to receive the benefit, patients 
forfeit any conventional treatment for the condition. This may feel to the patient that they are 
“giving up” or resigning themselves to death. 
 
A barrier related to getting timely access to palliative care is physicians and other 
healthcare staff not initiating conversations around palliative care or EOL issues. This may be 
due to the lack of incentives offered to healthcare professionals to initiate EOL conversations and 
a lack of education around palliative care and when to discuss the topic. Doctors may feel that 
they do not have enough time, resources, or knowledge to have these types of discussions with 
their patients and therefore do not initiate the conversation until it is too late to have any valuable 
impact. 
 
Recommendations to limit barriers 
 
1. Medicare benefit should include home-based palliative care without the requirement to 
forego treatment 
 
Medicare should cover home-based palliative care similarly to the way Medicare covers 
hospice benefits but without the requirement to be terminally ill, have six months or less to live, 
and to forego treatment. Palliative care should be available for those patients who wish to receive 
care at home, but may also want to continue getting life-saving treatment.  The current Medicare 
hospice model does not address patients with multiple chronic conditions and ambiguous 
prognoses. Providing palliative care earlier in the course of disease leads to better health 
outcomes, higher satisfaction with care and reductions in healthcare costs (California HealthCare 
Foundation, 2013). There is also considerable value in the simultaneous delivery of palliative 
and curative care.  
 
If Medicare included a benefit for home-based palliative care that did not require terminal 
illness and the choice to forego treatment, many more people would benefit from improved 
quality of life through palliative care and healthcare costs may be reduced. Medicare is already 
spending about $15 billion on hospice a year and 34.5 percent of the hospice patients receive a 
week or less of care (NHPCO, 2015). If home-based palliative care was offered to those same 
patients earlier in their illness trajectory, costs could potentially be avoided by reducing 
unnecessary care and managing high-need, “at risk” patients. 
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2. Compensation to healthcare providers for discussing and integrating palliative care  
 
The 2014 Institute of Medicine report, “Dying in America,” was released by a committee 
of 21 experts that calls the U.S. EOL care system, a large part of which is palliative care, 
“broken” and recommends several ways to improve care. One of the recommendations is 
reimbursing providers to discuss palliative care and advance planning with their patients. 
Incentives under fee-for-service Medicare result in increased use of medical services and late 
enrollment in hospice, which can jeopardize the quality of EOL care and add to costs. 
Incentivizing provisions of comprehensive palliative care and discouraging the use of costly and 
unnecessary medical procedures can improve patient outcomes and reduce healthcare costs 
(IOM, 2014).  
 
The 2013 MEDPAC report also recommends a Medicare payment to compensate 
physicians or interdisciplinary teams for voluntary advanced care planning. Providing 
compensation to physicians and other healthcare providers for discussing palliative care options 
and coordinating care would increase the number of patients who understand their care and 
treatment options. Over time, the savings to Medicare due to reduced unnecessary spending 
would help offset the cost of Medicare-financed incentives to healthcare providers. Federal or 
state governments could subsidize incentives for private practice physicians contingent on 
meeting quality standards. 
 
3. Better training for health professionals on palliative care topics 
 
There needs to be improved training of health professionals on issues like patient-
centered care and palliative care as a longer term approach in improving care for patients with 
advanced illness. According to the 2014 MEDPAC report, very short hospice stays are still 
common which indicates that patients enter hospice in the last week or so of their life, unable to 
receive the full benefit of palliative care. This may be due to physicians’ reluctance to have 
conversations about hospice or death, difficulty in some patients and families to accept death, 
and financial incentives in the fee-for-service system which value volume over quality 
(MEDPAC, 2014). The IOM report (2014) recommends improving palliative care training 
among all physicians. Educational institutions, credentialing bodies, accrediting boards, state 
regulatory agencies and healthcare delivery organizations should establish appropriate training, 
certification and licensure requirements to strengthen palliative care knowledge and skills of all 
physicians who care for patients with advanced illness (IOM, 2014). Training of healthcare 
professionals needs to emphasize high-quality care and comfort of the patient, including home-
based palliative care options and advanced care planning. Acknowledging advanced illness and 
mortality provides an opportunity to deliver high standards of care, grounded in choice and 
responsiveness to needs for both the patient and their family.  
 
When palliative care is taught, results can be impressive. A systematic review by Bickel-
Swenson (2007) found that EOL educational curricula and clinical training found in a wide range 
of formats improved the competency of medical students. Authors found a 23 percent 
improvement in knowledge, a 56 percent improvement in feelings of competence, and a 29 
percent decrease in concerns. George Washington University includes a standardized patient case 
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on palliative care and a course on medical interviewing and decision making. The University of 
Rochester includes content on advance care planning, chronic pain management, and discussion 
of treatment goals. The Association of American Medical Colleges is in collaboration with the 
Coalition to Transform Advanced Care to identify relevant core competencies. 
The time to act is now 
 
The aging of the American population is quickly expanding the healthcare burden, in 
large part by the 66 percent of older adults who have multiple chronic conditions. Treating 
advanced illness and chronic conditions in the older population is complex and expensive. 
Medicare spending is expected to increase from $555 billion in 2011 to $903 billion in 2020. As 
the U.S. healthcare system struggles to keep up with the demand for care, there will be an 
increasing need for high-quality palliative care in all settings, but particularly home-based 
settings. Patients and their families should have the choice to use home-based palliative care 
when it is available, without the burden of financial or accessibility barriers. Providing this 
home-based option will greatly alleviate the strain on inpatient settings and will reduce hospital 
and patient costs. An approach toward high-quality care and coordination and away from over-
treating or inappropriately treating patients will improve quality of life as well as reduce 
unnecessary medical costs. It is imperative that improvements in quality of palliative care and 
access to care are made so that all Americans, regardless of their financial status or medical 
prognosis, receive the highest quality care possible. 
